← Browse by Condition
Medical Condition

chronic heart failure

Total Trials
9
Recruiting Now
9
Trial Phases
Phase 4, Phase 3, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for chronic heart failure sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — chronic heart failure Clinical Trials

How many clinical trials are currently recruiting for chronic heart failure?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for chronic heart failure, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for chronic heart failure?
chronic heart failure research spans Phase 1 (2 trials), Phase 2 (1 trial), Phase 3 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a chronic heart failure clinical trial?
Eligibility criteria for chronic heart failure trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
2
Top Sponsors
Aristotle University Of Thessaloniki 1 trial
University Medical Centre Ljubljana 1 trial
Pr. Nicolas GIRERD 1 trial
Pharmacosmos A/S 1 trial
Tasly Pharmaceutical Group Co., Ltd 1 trial

Recruiting Clinical Trials

NCT06036615
Recruiting
The Effect of Exercise Training and Detraining on Frailty and Fall Risk in Patients With Chronic Heart Failure
Enrollment
100 pts
Location
Greece
Sponsor
Aristotle University Of Thessa...
View Trial →
NCT07405944 Phase 4
Recruiting
Vericiguat and Reverse Remodeling Indices in Heart Failure
Enrollment
60 pts
Location
Slovenia
Sponsor
University Medical Centre Ljub...
View Trial →
NCT05089162
Recruiting
CHF-COV Reduced (Chronic Heart Failure With Reduced Ejection Fraction - COngestion eValuation)
Enrollment
200 pts
Location
France
Sponsor
Pr. Nicolas GIRERD
View Trial →
NCT06929806 Phase 3
Recruiting
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
Enrollment
1,900 pts
Location
United States
Sponsor
Pharmacosmos A/S
View Trial →
NCT07265349 Phase 1, Phase 2
Recruiting
A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure
Enrollment
51 pts
Location
China
Sponsor
Tasly Pharmaceutical Group Co....
View Trial →
NCT06706791 Phase 4
Recruiting
Effect of Empagliflozin on Quality of Life in Chronic Heart Failure Patients With Diabetes Mellitus Type II
Enrollment
156 pts
Location
Pakistan
Sponsor
Fazaia Ruth Pfau Medical Colle...
View Trial →
NCT04471129
Recruiting
Non-invasive Ventilation and High-speed Oxygen Therapy Effects on Heart Function - HiFlow-Heart Study
Enrollment
30 pts
Location
France
Sponsor
University Hospital, Rouen
View Trial →
NCT07490054 Phase 1
Recruiting
Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure
Enrollment
40 pts
Location
United States
Sponsor
Melana Yuzefpolskaya, MD
View Trial →
NCT06785506
Recruiting
Multiple-biomarker Approach for Individualized Treatment of Heart Failure with Preserved Ejection Fraction
Enrollment
200 pts
Location
Netherlands
Sponsor
Erasmus Medical Center
View Trial →

Related Conditions

heart failure with reduced ejection fraction hfref (1) reduced ventricular ejection fraction (1) iron deficiencies (1) coronary artery bypass grafting cabg (1) chronic ischemic cardiomyopathy (1) heart failure with preserved ejection fraction (1) heart failure diastolic (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology